Literature DB >> 24418534

The EHV-1 UL4 protein that tempers viral gene expression interacts with cellular transcription factors.

Yunfei Zhang1, Robert A Charvat1, Seong K Kim1, Dennis J O'Callaghan2.   

Abstract

The UL4 gene is conserved within the genome of defective interfering particles of equine herpesvirus type 1 (EHV-1) that mediate persistent infection. Here, we show that the UL4 protein inhibits EHV-1 reporter gene expression by decreasing the level of transcribed mRNA. The UL4 protein did not bind any gene class of EHV-1 promoters in electromobility or chromatin immunoprecipitation assays, but directly interacted with the TATA box-binding protein (TBP) and the carboxy-terminal domain of RNA polymerase II both in vitro (GST-pulldown assays) and in infected cells (coimmunoprecipitation analyses). Microarray analyses of the expression of the 78 EHV-1 genes revealed that viral late genes important for virion assembly displayed enhanced expression in cells infected with UL4-null virus as compared to wild-type or UL4-restored EHV-1. Quantitative PCR analyses showed that viral DNA replication was not retarded in cells infected with the UL4-null virus as compared to wild-type EHV-1.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA microarray; Defective interfering particles; Equine herpesvirus 1; Herpesvirus gene regulation; Inhibition; RNA polymerase II; Transcription; Transcription factors

Mesh:

Substances:

Year:  2013        PMID: 24418534      PMCID: PMC6699183          DOI: 10.1016/j.virol.2013.11.005

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  59 in total

1.  The gamma2 late glycoprotein K promoter of equine herpesvirus 1 is differentially regulated by the IE and EICP0 proteins.

Authors:  S K Kim; D E Bowles; D J O'callaghan
Journal:  Virology       Date:  1999-04-10       Impact factor: 3.616

2.  Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription.

Authors:  P Komarnitsky; E J Cho; S Buratowski
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

Review 3.  Regulation of transcription elongation by phosphorylation.

Authors:  Michael S Kobor; Jack Greenblatt
Journal:  Biochim Biophys Acta       Date:  2002-09-13

4.  Molecular characterizations of the equine herpesvirus 1 ETIF promoter region and translation initiation site.

Authors:  S K Kim; D J O'Callaghan
Journal:  Virology       Date:  2001-07-20       Impact factor: 3.616

5.  Characterization of the trans-activation properties of equine herpesvirus 1 EICP0 protein.

Authors:  D E Bowles; S K Kim; D J O'Callaghan
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Characterization of the transactivation domain of the equine herpesvirus type 1 immediate-early protein.

Authors:  K A Buczynski; S K Kim; D J O'Callaghan
Journal:  Virus Res       Date:  1999-12-15       Impact factor: 3.303

7.  The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription.

Authors:  Gilles Gaudray; Frederic Gachon; Jihane Basbous; Martine Biard-Piechaczyk; Christian Devaux; Jean-Michel Mesnard
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  The defective interfering particles of equine herpesvirus 1 encode an ICP22/ICP27 hybrid protein that alters viral gene regulation.

Authors:  M Chen; K A Garko-Buczynski; Y Zhang; D J O'Callaghan
Journal:  Virus Res       Date:  1999-02       Impact factor: 3.303

9.  Interaction of the equine herpesvirus 1 EICP0 protein with the immediate-early (IE) protein, TFIIB, and TBP may mediate the antagonism between the IE and EICP0 proteins.

Authors:  Seong K Kim; Hyung K Jang; Randy A Albrecht; Wilbert A Derbigny; Yunfei Zhang; Dennis J O'Callaghan
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  Characterization of the regulatory functions of the equine herpesvirus 1 immediate-early gene product.

Authors:  R H Smith; G B Caughman; D J O'Callaghan
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.